XML 11 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Net product sales $ 4,283,979 $ 2,654,186 $ 11,116,279 $ 6,941,042
Operating expenses:        
Cost of goods sold $ 101,977 $ 104,024 $ 311,269 $ 238,031
Cost, Product and Service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember
Research and development $ 5,320 $ 11,677 $ 56,516 $ 16,322
Selling, general and administrative 5,314,370 3,824,142 14,746,777 10,697,128
Total operating expenses 5,421,667 3,939,843 15,114,562 10,951,481
Loss from operations (1,137,688) (1,285,657) (3,998,283) (4,010,439)
Other income (expense):        
Interest income 107,507 99,294 338,894 226,353
Interest expense (126,027) (126,027) (373,973) (375,342)
Total other expense (18,520) (26,733) (35,079) (148,989)
Net loss $ (1,156,208) $ (1,312,390) $ (4,033,362) $ (4,159,428)
Net loss per share of common stock, basic $ (0.45) $ (0.94) $ (1.58) $ (3.01)
Net loss per share of common stock, diluted $ (0.45) $ (0.94) $ (1.58) $ (3.01)
Weighted-average shares used to compute basic net loss per share 2,557,408 1,399,882 2,553,121 1,381,703
Weighted-average shares used to compute diluted net loss per share 2,557,408 1,399,882 2,553,121 1,381,703